Table 1 Study population characteristics.

From: Determinants of retinopathy and short-term neurological outcomes after cerebral malaria

 

Deceased

(n = 20)

n (%)

Non-deceased

(n = 50)

n (%)

p-value

Age

  

0.389

 4 years old or less

11 (55.0)

33 (66.0)

 

 More than 4 years old

9 (45.0)

17 (34.0)

 

Gender

  

0.357

 Female

10 (50.0)

31 (62.0)

 

 Male

10 (50.0)

19 (38.0)

 

Admitting hospital

  

0.255

 Calavi

13 (65.0)

25 (50)

 

 CHUMEL

7 (35.0)

25 (50)

 

Medical consultation

  

1.000

 Yes

18 (90.0)

45 (90.0)

 

 No

2 (10.0)

5 (10.0)

 

Traditional consultation

  

0.819

 Yes

9 (45.0)

21 (42.0)

 

 No

11 (55.0)

29 (58.0)

 

Pre-admission treatment

   

Antibiotic

  

0.105

 Yes

9 (45.0)

33 (66.0)

 

 No

11 (55.0)

17 (34.0)

 

Anti-epileptic

  

0.053

 Yes

4 (20.0)

22 (44.9)

 

 No

16 (80.0)

27 (55.1)

 

Onset of illness with coma

  

0.213

 Yes

16 (80.0)

46 (92.0)

 

 No

4 (20.0)

4 (8.0)

 

Clinical and biological examinations

   

Blantyre’s score

  

0.007*

 2

9 (45.0)

39 (78.0)

 

 0 or 1

11 (55.0)

11 (22.0)

 

Multiple convulsions

  

0.939

 Yes

10 (50.0)

24 (49.0)

 

 No

10 (50.0)

25 (51.0)

 

Respiratory distress

  

0.068

 Yes

8 (40.0)

9 (18.0)

 

 No

12 (60.0)

41 (82.0)

 

Jaundice or elevated bilirubin > 50 µmol/L

  

0.004*

 Yes

15 (75.0)

18 (36.7)

 

 No

5 (25.0)

31 (63.3)

 

Hypoglycaemia (glucose < 2.2 mmol/L)

  

< 0.001*

 Yes

14 (70.0)

11 (22.0)

 

 No

6 (30.0)

39 (78.0)

 

Acidosis (plasma bicarbonate < 15 mmol/L)

  

< 0.001*

 Yes

17 (85.0)

16 (32.6)

 

 No

3 (15.0)

33 (67.4)

 

Severe anaemia (haemoglobin < 50 g/L, haematocrit < 15%)

  

1.000

 Yes

8 (40.0)

20 (40.0)

 

 No

12 (60.0)

30 (60.0)

 
  1. p-value < 0.20 are in bold. *p-value < 0.05.